301515.SZ
Sichuan Gangtong Medical Equipment Group Co., Ltd.
SZSE · C 制造业 · CN
CNY 17.80
+2.42%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 747.8M | 721.6M | 754.1M | 842.4M | 768.5M |
| Cost of Revenue | 584.7M | 558.1M | 604.2M | 625.2M | 543.8M |
| Gross Profit | 163.1M | 163.5M | 149.8M | 217.2M | 224.8M |
| Operating Expenses | |||||
| R&D Expense | 25.5M | 26.0M | 24.2M | 29.9M | 26.5M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 39.4M | 36.4M | 31.8M | 37.3M | 31.5M |
| Selling & Marketing Expense | 37.9M | 38.9M | 40.0M | 41.1M | 46.1M |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 109.8M | 107.9M | 97.0M | 113.7M | 112.8M |
| Cost and Expenses | 694.6M | 666.0M | 701.2M | 738.9M | 656.5M |
| Operating Income (EBIT) | (12.5M) | (9.2M) | 13.3M | 97.3M | 83.6M |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (12.0M) | (8.7M) | 15.1M | 94.9M | 83.3M |
| Income Tax Expense | (3.8M) | (3.5M) | 678.9K | 11.8M | 9.4M |
| Bottom Line | |||||
| Net Income | (4.9M) | (2.6M) | 14.4M | 83.1M | 73.9M |
| Earnings from Cont. Ops | (8.2M) | (5.2M) | 14.4M | 83.1M | 73.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (4.9M) | (2.6M) | 14.4M | 83.1M | 73.9M |
| Per Share | |||||
| Basic EPS | (CN¥0.05) | (CN¥0.03) | CN¥0.15 | CN¥0.97 | CN¥0.99 |
| Diluted EPS | (CN¥0.05) | (CN¥0.03) | CN¥0.15 | CN¥0.97 | CN¥0.99 |
| Revenue Per Share | CN¥7.78 | CN¥7.47 | CN¥7.60 | CN¥9.86 | CN¥10.25 |
| Shares | |||||
| Basic Shares Outstanding | 96.1M | 96.5M | 99.3M | 85.4M | 75.0M |
| Diluted Shares Outstanding | 96.1M | 96.5M | 99.3M | 85.4M | 75.0M |
| Profitability Metrics | |||||
| EBITDA | — | (351.6K) | 19.9M | 103.2M | 90.1M |
| D&A | — | 8.9M | 6.6M | 5.9M | 6.5M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026